IAM Advisory’s Idexx Laboratories IDXX Stock Holding History

IAM Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,531	Closed	-$1.39M	–	81
2022 Q1	$1.39M	Buy	2,531 +15	+0.6%	+$7.89K	0.56%	24
2021 Q4	$1.41M	Sell	2,516 -67	-3%	-$42.1K	0.56%	24
2021 Q3	$1.58M	Buy	+2,583	New	+$1.74M	0.67%	21
2021 Q2	–	Sell	-2,559	Closed	-$1.41M	–	65
2021 Q1	$1.41M	Buy	2,559 +11	+0.4%	+$5.51K	0.61%	16
2020 Q4	$1.24M	Buy	+2,548	New	+$1.14M	0.62%	20

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

IAM Advisory's IDXX Position: Q2 2022 in Review

IAM Advisory sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 2,531 shares — an estimated $1.39M sold.

IAM Advisory first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $1.58M in Q3 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

IAM Advisory reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
IAM Advisory sold 2,531 Idexx Laboratories shares in Q2 2022, an estimated $1.39M.
IAM Advisory first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
IAM Advisory's Idexx Laboratories position peaked at $1.58M in Q3 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on IAM Advisory's 13F filing for Q2 2022, filed 12 Jul 2022.